BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7699112)

  • 1. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrain.
    Arendt T; Marcova L; Bigl V; Brückner MK
    J Comp Neurol; 1995 Jan; 351(2):169-88. PubMed ID: 7699111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
    J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.
    Morawski M; Brückner G; Jäger C; Seeger G; Arendt T
    Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease.
    Mufson EJ; Kordower JH
    Prog Clin Biol Res; 1989; 317():401-14. PubMed ID: 2557638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer's disease].
    Kobayashi K; Fukutani Y; Nakamura I; Kawasaki Y; Suzuki M; Yamaguchi N; Nakanishi I
    No To Shinkei; 1990 Apr; 42(4):345-51. PubMed ID: 2390367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
    Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
    Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The connections of the septal region in the rat.
    Swanson LW; Cowan WM
    J Comp Neurol; 1979 Aug; 186(4):621-55. PubMed ID: 15116692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An autopsy case of amyotrophic lateral sclerosis with concomitant Alzheimer's and incidental Lewy body diseases].
    Su M; Wakabayashi K; Tanno Y; Inuzuka T; Takahashi H
    No To Shinkei; 1996 Oct; 48(10):931-6. PubMed ID: 8921532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2).
    Rüb U; Farrag K; Seidel K; Brunt ER; Heinsen H; Bürk K; Melegh B; von Gall C; Auburger G; Bohl J; Korf HW; Hoche F; den Dunnen W
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):634-43. PubMed ID: 23363055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.